Lista de obras - Peter Mollee - Dominio Público Uruguay

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

artículo científico publicado en 2017

A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.

artículo científico publicado en 2008

A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins.

artículo científico publicado en 2017

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

artículo científico publicado en 2012

A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.

artículo científico publicado en 2006

Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survival.

artículo científico publicado en 2013

Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?

scientific article published on 01 February 2005

An Individualized Exercise Intervention for People with Multiple Myeloma-Study Protocol of a Randomized Waitlist-Controlled Trial

artículo científico publicado en 2022

Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases

artículo científico publicado en 2006

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

artículo científico publicado en 2017

Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory states

artículo científico publicado en 2009

CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro

scientific article published on 19 April 2012

CD62L as a therapeutic target in chronic lymphocytic leukemia.

artículo científico publicado en 2013

Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study

artículo científico publicado en 2016

Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study

article

Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.

artículo científico publicado en 2011

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

artículo científico publicado en 2015

Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.

artículo científico publicado en 2001

Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.

artículo científico publicado en 2015

Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome

scientific article published on 08 January 2020

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

artículo científico publicado en 2018

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis

artículo científico publicado en 2015

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

artículo científico publicado en 2016

Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

scientific article published on 01 July 2007

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

artículo científico publicado en 2014

Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system

artículo científico publicado en 2006

Epstein-Barr virus T-cell immunity despite rituximab.

artículo científico publicado en 2007

Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis.

artículo científico publicado en 2013

Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis.

artículo científico publicado en 2016

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

scientific article published on 20 April 2018

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease ⬇️

artículo científico publicado el 1 de enero de 2012

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.

artículo científico publicado en 2012

How to diagnose amyloidosis.

artículo científico publicado en 2014

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

scientific article published on 01 November 2018

Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry

artículo científico publicado en 2016

Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.

artículo científico publicado en 2016

Increased lipid concentration is associated with increased hemolysis

artículo científico publicado en 2005

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

artículo científico publicado en 2014

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.

artículo científico publicado en 2015

Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange

artículo científico publicado en 2015

Malabsorption Secondary to Gout-Induced Amyloidosis.

artículo científico publicado en 2017

Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

artículo científico publicado en 2015

Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?

artículo científico publicado en 2017

Monitoring of light chain myeloma - time for a change.

artículo científico publicado en 2017

Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.

artículo científico publicado en 2017

Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population

scientific article published on 06 December 2010

Palifermin-induced acanthosis nigricans

artículo científico publicado en 2007

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

artículo científico publicado en 2016

Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial

artículo científico publicado en 2017

Physical Activity in People with Multiple Myeloma: Associated Factors and Exercise Program Preferences

artículo científico publicado en 2020

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

artículo científico publicado en 2006

Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.

artículo científico publicado en 2010

Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.

artículo científico publicado en 2014

Promyelocytic transformation of polycythaemia vera (PV) ⬇️

artículo científico publicado el 1 de diciembre de 1997

Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies

artículo científico publicado en 2016

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

scientific article published on 01 February 2019

Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma.

artículo científico publicado en 2002

Rapid Molecular Profiling of Myeloproliferative Neoplasms Using Targeted Exon Resequencing of 86 Genes Involved in JAK-STAT Signaling and Epigenetic Regulation.

artículo científico publicado en 2016

Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand ⬇️

artículo científico publicado el 8 de marzo de 2012

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

artículo científico

Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor

scientific article published on 01 February 1999

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

artículo científico publicado en 2011

Serum free light chains for monitoring multiple myeloma

scientific article published on 01 February 2005

Stem cell transplantation for mantle cell lymphoma: if, when and how?

artículo científico publicado en 2005

Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.

artículo científico publicado en 2014

The Clinical Impact of Proteomics in Amyloid Typing

artículo científico publicado en 2021

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

artículo científico publicado en 2006

The Utility of 99mTc-DPD Scintigraphy in the Diagnosis of Cardiac Amyloidosis: An Australian Experience.

artículo científico publicado en 2017

The duality of macrophage function in chronic lymphocytic leukaemia

artículo científico publicado en 2017

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

artículo científico publicado en 2019

The reporting of serum protein electrophoresis to clinicians

scientific article published on 01 August 2005

The treatment of paraprotein-related kidney disease

artículo científico publicado en 2017

Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes.

artículo científico publicado en 2015

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

artículo científico publicado en 2010

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

artículo científico publicado en 2017

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

artículo científico

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group

artículo científico publicado en 2015

Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital

artículo científico publicado en 2013

Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.

artículo científico publicado en 2017

Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study

artículo científico publicado en 2012

Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity

artículo científico publicado en 2012

WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation.

artículo científico publicado en 2011

Lista de obras de Peter Mollee

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma.

A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse.

A global call to arms for clinical laboratories - Harmonised quantification and reporting of monoclonal proteins.

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.

Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survival.

Allogeneic stem cell transplantation for mantle cell lymphoma--does it deserve a better look?

An Individualized Exercise Intervention for People with Multiple Myeloma-Study Protocol of a Randomized Waitlist-Controlled Trial

Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory states

CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro

CD62L as a therapeutic target in chronic lymphocytic leukemia.

Cardiac Amyloid Imaging with 18F-Florbetaben PET: A Pilot Study

Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study

Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.

Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.

Concurrent lipidomics and proteomics on malignant plasma cells from multiple myeloma patients: Probing the lipid metabolome

Considerations for pre-transfusion immunohaematology testing in patients receiving the anti-CD38 monoclonal antibody daratumumab for the treatment of multiple myeloma.

Deliverability and efficacy of R-CHOP chemotherapy in very elderly patients with diffuse large B-cell lymphoma: an Australian retrospective analysis

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry

Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

Effects of hyperlipidemia on plasma sodium, potassium, and chloride measurements by an indirect ion-selective electrode measuring system

Epstein-Barr virus T-cell immunity despite rituximab.

Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis.

Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosis.

Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease ⬇️

Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.

How to diagnose amyloidosis.

Immunosuppression is associated with clinical features and relapse risk of B cell posttransplant lymphoproliferative disorder: A retrospective analysis based on the prospective, international, multicenter PTLD-1 trials

Implementation and evaluation of amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry

Increased FcγRIIB dominance contributes to the emergence of resistance to therapeutic antibodies in chronic lymphocytic leukaemia patients.

Increased lipid concentration is associated with increased hemolysis

Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

International prognostic index, type of transplant and response to rituximab are key parameters to tailor treatment in adults with CD20-positive B cell PTLD: clues from the PTLD-1 trial.

Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchange

Malabsorption Secondary to Gout-Induced Amyloidosis.

Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?

Monitoring of light chain myeloma - time for a change.

Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome.

Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population

Palifermin-induced acanthosis nigricans

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia.

Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial

Physical Activity in People with Multiple Myeloma: Associated Factors and Exercise Program Preferences

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.

Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.

Promyelocytic transformation of polycythaemia vera (PV) ⬇️

Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma.

Rapid Molecular Profiling of Myeloproliferative Neoplasms Using Targeted Exon Resequencing of 86 Genes Involved in JAK-STAT Signaling and Epigenetic Regulation.

Recommendations for standardized reporting of protein electrophoresis in Australia and New Zealand ⬇️

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

Serum free light chains for monitoring multiple myeloma

Stem cell transplantation for mantle cell lymphoma: if, when and how?

Successful treatment of iatrogenic multicentric Castleman's disease arising due to recrudescence of HHV-8 in a liver transplant patient.

The Clinical Impact of Proteomics in Amyloid Typing

The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization

The Utility of 99mTc-DPD Scintigraphy in the Diagnosis of Cardiac Amyloidosis: An Australian Experience.

The duality of macrophage function in chronic lymphocytic leukaemia

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

The reporting of serum protein electrophoresis to clinicians

The treatment of paraprotein-related kidney disease

Transcriptomic analysis of monocytes and macrophages derived from CLL patients which display differing abilities to respond to therapeutic antibody immune complexes.

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population

Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.

Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group

Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital

Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting.